Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Daly

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
The EMBO Journal|February 1, 1992
SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gammaD Rotin, B Margolis, M Mohammadi, et al.
The Journal of Biological Chemistry|March 30, 2001
Identification of a novel human tankyrase through its interaction with the adaptor protein Grb14R J Lyons, R Deane, D K Lynch, et al.
Oncogene|October 31, 1997
EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancerR Hui, D H Campbell, C S Lee, et al.
Cell|August 7, 1992
The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signalingE J Lowenstein, R J Daly, A G Batzer, et al.
International Journal of Cancer|October 31, 2000
Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expressionS S Yip, A J Crew, J M Gee, et al.
Oncogene|July 4, 2012
Functional characterization of cancer-associated Gab1 mutationsC Ortiz-Padilla, D Gallego-Ortega, B C Browne, et al.
Oncogene|October 14, 2008
Annexin A6 inhibits Ras signalling in breast cancer cellsS Vilá de Muga, P Timpson, L Cubells, et al.
Leukemia|August 4, 2012
Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitorsF U Wöhrle, S Halbach, K Aumann, et al.
Oncogene|July 17, 2012
Annexin A6 is a scaffold for PKCα to promote EGFR inactivationM Koese, C Rentero, B P Kota, et al.
Molecular Endocrinology (Baltimore, Md.)|June 4, 2010
The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5H N Hilton, M Kalyuga, M J Cowley, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
The EMBO Journal|February 1, 1992
SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gammaD Rotin, B Margolis, M Mohammadi, et al.
The Journal of Biological Chemistry|March 30, 2001
Identification of a novel human tankyrase through its interaction with the adaptor protein Grb14R J Lyons, R Deane, D K Lynch, et al.
Oncogene|October 31, 1997
EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancerR Hui, D H Campbell, C S Lee, et al.
Cell|August 7, 1992
The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signalingE J Lowenstein, R J Daly, A G Batzer, et al.
International Journal of Cancer|October 31, 2000
Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expressionS S Yip, A J Crew, J M Gee, et al.
Oncogene|July 4, 2012
Functional characterization of cancer-associated Gab1 mutationsC Ortiz-Padilla, D Gallego-Ortega, B C Browne, et al.
Oncogene|October 14, 2008
Annexin A6 inhibits Ras signalling in breast cancer cellsS Vilá de Muga, P Timpson, L Cubells, et al.
Leukemia|August 4, 2012
Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitorsF U Wöhrle, S Halbach, K Aumann, et al.
Oncogene|July 17, 2012
Annexin A6 is a scaffold for PKCα to promote EGFR inactivationM Koese, C Rentero, B P Kota, et al.
Molecular Endocrinology (Baltimore, Md.)|June 4, 2010
The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5H N Hilton, M Kalyuga, M J Cowley, et al.
Pageof 8